Product
CCX282-B
3 clinical trials
3 indications
Indication
Crohn's diseaseIndication
Celiac DiseaseIndication
Crohn's DiseaseClinical trial
A Multinational, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's DiseaseStatus: Completed, Estimated PCD: 2008-08-01
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Testing CCX282-B in the Treatment of Celiac DiseaseStatus: Completed, Estimated PCD: 2008-06-01